Earnings History Data for Collegium Pharmaceutical, Inc. (COLL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171, COL-003 and COL-172 which are in different clinical trial. It developed a formulation platform technology, DETERx, for the treatment of chronic pain. Collegium Pharmaceutical Inc. is based in CUMBERLAND, United States.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-08-2025	PM		COLL	Collegium Pharmaceutical, Inc.	999.62	1.47	1.43	1.43	Collegium Pharmaceutical Non-GAAP EPS of $1.68 misses by $0.17, revenue of $188M beats by $7.12M [8/7/2025 7:34 AM]	32.98	3.23 (10.86%)	29.75	0.0 (0.00%)	23.23 - 42.29	780,900	290,000	17,333
Collegium Pharmaceutical Q2 2025 Earnings Preview [8/6/2025 11:37 AM] Collegium Pharmaceutical Non-GAAP EPS of $1.68 misses by $0.17, revenue of $188M beats by $7.12M [8/7/2025 7:34 AM] Collegium raises 2025 revenue guidance to $760M as Jornay PM growth accelerates [8/7/2025 2:01 PM]
08-05-2025	AH		COLL	Collegium Pharmaceutical, Inc.	851.05	1.23	1.29	1.32	Collegium Pharmaceutical Non-GAAP EPS of $1.49 beats by $0.04, revenue of $177.8M beats by $4.72M [5/8/2025 4:04 PM]	28.81	1.54 (5.63%)	27.27	0.0 (0.00%)	23.23 - 42.29	460,707	0	24,870
Collegium Pharmaceutical Non-GAAP EPS of $1.49 beats by $0.04, revenue of $177.8M beats by $4.72M [5/8/2025 4:04 PM] Collegium pharmaceutical targets $135M in Jornay PM revenue for 2025 amid sales force expansion [5/9/2025 2:05 AM] Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress [2025-05-08 04:01PM] ElectroCore, Inc. (ECOR) Reports Q1 Loss, Misses Revenue Estimates [May-07-25 06:15PM] Collegium Pharmaceutical Inc (COLL) Q1 2025: Everything You Need To Know Ahead Of Earnings [May-07-25 10:28AM] Collegium Pharmaceutical Inc (COLL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth ... [2025-05-09 03:42AM] Compared to Estimates, Collegium Pharmaceutical (COLL) Q1 Earnings: A Look at Key Metrics [May-08-25 05:30PM] Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Surpass Estimates [May-08-25 05:15PM] Collegium Pharmaceutical: Q1 Earnings Snapshot [May-08-25 04:11PM]
27-02-2025	AH		COLL	Collegium Pharmaceutical, Inc.	642.69	1.63	1.41	1.45	Collegium Pharmaceutical Non-GAAP EPS of $1.75 beats by $0.21, revenue of $181.9M beats by $2.22M [2/27/2025 4:04 PM]	29.09	0.67 (2.35%)	30.88	2.46 (8.66%)	27.84 - 42.29	539,642	320,000	115,789
Collegium Pharmaceutical Non-GAAP EPS of $1.75 beats by $0.21, revenue of $181.9M beats by $2.22M [2/27/2025 4:04 PM] Collegium Reports Record Fourth Quarter and Full-Year 2024 Financial Results [2025-02-27 04:01PM] Seeking Clues to Collegium Pharmaceutical (COLL) Q4 Earnings? A Peek Into Wall Street Projections for Key Metrics [Feb-26-25 09:15AM] Collegium Pharmaceutical (COLL) Reports Earnings Tomorrow: What To Expect [Feb-26-25 08:12AM] What To Expect From Collegium Pharmaceutical Inc (COLL) Q4 2024 Earnings [Feb-26-25 07:53AM]
07-11-2024	AH		COLL	Collegium Pharmaceutical, Inc.	1,080	1.48	1.54	1.21	Collegium Pharmaceutical Non-GAAP EPS of $1.61 beats by $0.02, revenue of $159.3M beats by $3.73M [11/7/2024 4:43 PM]	32.20	-2.51 (-7.22%)	34.86	0.15 (0.43%)	22.98 - 42.29	877,725	320,000	217
Collegium names Vikram Karnani as CEO [11/7/2024 4:07 PM] Collegium Pharmaceutical Non-GAAP EPS of $1.61 beats by $0.02, revenue of $159.3M beats by $3.73M [11/7/2024 4:43 PM] Collegium Pharmaceutical: Q3 Earnings Snapshot [2024-11-07 04:34PM] Collegium Reports Record Third Quarter 2024 Financial Results [2024-11-07 04:02PM] Collegium Appoints Vikram Karnani as Chief Executive Officer [2024-11-07 04:01PM] What To Expect From Collegium Pharmaceutical Inc (COLL) Q3 2024 Earnings [Nov-06-24 07:25AM]
08-08-2024	AH		COLL	Collegium Pharmaceutical, Inc.	1,120	1.43	1.40	1.13	Collegium Pharmaceutical Non-GAAP EPS of $1.62 beats by $0.13, revenue of $145.3M beats by $0.74M [8/8/2024 4:05 PM]	35.24	-0.08 (-0.21%)	36.00	0.68 (1.93%)	20.95 - 40.95	278,938	740,000	10,221
Collegium Pharmaceutical Non-GAAP EPS of $1.62 beats by $0.13, revenue of $145.3M beats by $0.74M [8/8/2024 4:05 PM]
09-05-2024	AH		COLL	Collegium Pharmaceutical, Inc.	1,190	1.32	1.36	1.18	Collegium Pharmaceutical Non-GAAP EPS of $1.45 misses by $0.02, revenue of $144.9M misses by $2.04M [5/9/2024 4:16 PM]	31.57	-6.29 (-16.60%)	35.20	-2.66 (-7.03%)	20.83 - 40.95	2,077,155	300,000	6,558
Collegium downgraded by Piper Sandler over valuation [5/10/2024 1:12 PM] Collegium announces CEO Joe Ciaffoni to step down [5/9/2024 4:29 PM] Collegium Pharmaceutical Non-GAAP EPS of $1.45 misses by $0.02, revenue of $144.9M misses by $2.04M [5/9/2024 4:16 PM]
22-02-2024	AH		COLL	Collegium Pharmaceutical, Inc.	1,060	1.45	1.20	0.98	Collegium Pharmaceutical Non-GAAP EPS of $1.58 beats by $0.33, revenue of $149.7M beats by $2.16M [2/22/2024 4:41 PM]	36.27	3.46 (10.55%)	34.30	1.49 (4.54%)	20.83 - 36.34	923,465	360,000	491,993
Collegium Pharmaceutical Non-GAAP EPS of $1.58 beats by $0.33, revenue of $149.7M beats by $2.16M [2/22/2024 4:41 PM]
07-11-2023	AH		COLL	Collegium Pharmaceutical, Inc.	771.10	1.21	1.11	0.96	Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10, revenue of $136.7M misses by $2.84M [11/7/2023 4:08 PM]	23.11	1.43 (6.60%)	21.68	0.0 (0.00%)	18.87 - 30.22	369,964	270,000	6,174
Collegium Pharmaceutical Non-GAAP EPS of $1.34 beats by $0.10, revenue of $136.7M misses by $2.84M [11/7/2023 4:08 PM]
03-08-2023	AH		COLL	Collegium Pharmaceutical, Inc.	787.72	1.13	1.11	-0.04	Collegium Pharmaceutical Non-GAAP EPS of $1.26 beats by $0.04, revenue of $135.5M misses by $2.91M [8/3/2023 4:14 PM]	23.51	1.49 (6.77%)	22.02	0.0 (0.00%)	15.40 - 30.22	1,661,798	270,000	5,430
Collegium Pharmaceutical Non-GAAP EPS of $1.26 beats by $0.04, revenue of $135.5M misses by $2.91M [8/3/2023 4:14 PM]
04-05-2023	AH	4:00 PM ET (May 4)	COLL	Collegium Pharmaceutical, Inc.	771.16	1.18	1.20	0.42	Collegium Pharmaceutical Non-GAAP EPS of $1.32 misses by $0.19, revenue of $144.8M beats by $6.47M [5/4/2023 5:00 PM]	22.91	0.71 (3.20%)	22.20	0.0 (0.00%)	14.04 - 30.22	594,109	420,000	6,415
Collegium Pharmaceutical Non-GAAP EPS of $1.32 misses by $0.19, revenue of $144.8M beats by $6.47M [5/4/2023 5:00 PM]
23-02-2023	AH	4:00 PM ET (Feb 23)	COLL	Collegium Pharmaceutical, Inc.	912.15	0.98	0.88	-0.73	Collegium Pharmaceutical Non-GAAP EPS of $1.09 misses by $0.17, revenue of $129.62M beats by $4.41M [2/23/2023 4:45 PM]	26.87	0.27 (1.02%)	26.60	0.0 (0.00%)	14.04 - 30.22	314,756	460,000	400
Collegium Pharmaceutical Non-GAAP EPS of $1.09 misses by $0.17, revenue of $129.62M beats by $4.41M [2/23/2023 4:45 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	COLL	Collegium Pharmaceutical, Inc.	633.04	0.96	1.04	0.22	Collegium Pharmaceutical GAAP EPS of $0.01 beats by $0.15, revenue of $127M beats by $2.64M [11/3/2022 4:18 PM]	18.82	0.79 (4.38%)	18.03	0.0 (0.00%)	14.04 - 22.89	332,211	170,000	12,400
Collegium Pharmaceutical GAAP EPS of $0.01 beats by $0.15, revenue of $127M beats by $2.64M [11/3/2022 4:18 PM] Collegium Reports Third Quarter 2022 Financial Results [Nov-03-22 04:01PM] Collegium Pharmaceutical (COLL) Lags Q3 Earnings Estimates [Nov-03-22 06:15PM]
04-08-2022	AH	4:00 PM ET (Aug 4)	COLL	Collegium Pharmaceutical, Inc.	581.28	-0.04	1.19	0.27	Collegium Pharmaceutical GAAP EPS of -$0.15 misses by $0.21, revenue of $123.55M beats by $2.33M [8/4/2022 4:22 PM]	20.09	1.58 (8.54%)	18.51	0.0 (0.00%)	14.04 - 25.22	494,895	180,000	24,668
Collegium Pharmaceutical GAAP EPS of -$0.15 misses by $0.21, revenue of $123.55M beats by $2.33M [8/4/2022 4:22 PM] Collegium Reports Second Quarter 2022 Financial Results [Aug-04-22 04:01PM]
10-05-2022	AH	4:00 PM ET (May 10)	COLL	Collegium Pharmaceutical, Inc.	498.67	0.42	0.82	0.41	Collegium Pharmaceutical GAAP EPS of -$0.39, revenue of $83.75M [5/10/2022 4:29 PM]	14.51	0.03 (0.21%)	14.40	-0.08 (-0.55%)	14.04 - 25.66	581,422	370,000	2,980
Collegium Pharmaceutical GAAP EPS of -$0.39, revenue of $83.75M [5/10/2022 4:29 PM] Collegium Reports First Quarter 2022 Financial Results [May-10-22 04:01PM] Collegium Pharmaceutical (COLL) Lags Q1 Earnings Estimates [May-10-22 05:55PM]
24-02-2022	AH	4:00 PM ET (Feb 24)	COLL	Collegium Pharmaceutical, Inc.	766.39	-0.73	0.86	0.20	Collegium Pharmaceutical GAAP EPS of -$0.73 misses by $1.08, revenue of $27.36M misses by $54.17M [2/24/2022 4:47 PM]	20.35	-1.05 (-4.91%)	20.00	-1.40 (-6.54%)	17.18 - 26.90	729,649	740,000	5,811
Collegium Pharmaceutical GAAP EPS of -$0.73 misses by $1.08, revenue of $27.36M misses by $54.17M [2/24/2022 4:47 PM] Esperion (ESPR) Q4 Earnings Beat, Product Sales Rise 49% [Feb-23-22 11:54AM] Halozyme (HALO) Q4 Earnings Top, Royalties Drive Revenues [Feb-23-22 11:31AM] Allogene (ALLO) Beats on Q4 Earnings, Resumes Clinical Studies [Feb-24-22 10:37AM] Collegium Reports Fourth Quarter and Full-Year 2021 Financial Results [Feb-24-22 04:01PM] Collegium Pharmaceutical (COLL) Reports Q4 Loss, Lags Revenue Estimates [Feb-24-22 05:30PM] United Therapeutics (UTHR) Q4 Earnings & Sales Miss, Stock Down [Feb-25-22 10:45AM] Emergent's (EBS) Q4 Earnings & Sales Beat, CDMO View Cut [Feb-25-22 11:05AM]
04-11-2021	AH	4:00 PM ET (Nov 4)	COLL	Collegium Pharmaceutical, Inc.	733.34	0.22	0.75	0.32	Collegium Pharmaceutical EPS misses by $0.14, misses on revenue [11/4/2021 4:43 PM]	19.04	-0.31 (-1.60%)	18.80	-0.55 (-2.84%)	17.67 - 26.91	575,464	370,000	2,671
Collegium Pharmaceutical EPS misses by $0.14, misses on revenue [11/4/2021 4:43 PM] Collegium Reports Third Quarter Fiscal 2021 Results [Nov-04-21 04:01PM] Collegium Pharmaceutical (COLL) Misses Q3 Earnings and Revenue Estimates [Nov-04-21 08:56PM] Collegium Pharmaceutical, inc (COLL) Q3 2021 Earnings Call Transcript [Nov-05-21 12:00PM]
05-08-2021	AH	4:00 PM ET (Aug 5)	COLL	Collegium Pharmaceutical, Inc.	890.00	0.27	0.34	0.23	Collegium Pharmaceutical EPS beats by $0.57, misses on revenue [8/5/2021 4:07 PM]	20.49	-4.35 (-17.53%)	21.65	-3.19 (-12.84%)	17.19 - 26.91	1,724,057	200,000	13,807
Is Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) ROE Of 25% Impressive? [Aug-04-21 03:06AM] Collegium Reports Strong Q2 Results with Cash Balance Growing to Over $200 Million [Aug-05-21 04:01PM] Collegium Pharmaceutical (COLL) Q2 Earnings and Revenues Miss Estimates [Aug-05-21 06:25PM] Collegium Pharmaceutical, inc (COLL) Q2 2021 Earnings Call Transcript [Aug-06-21 09:00AM]
06-05-2021	AH	4:00 PM ET (May 6)	COLL	Collegium Pharmaceutical, Inc.	785.40	0.41	0.30	0.01	Collegium Pharmaceutical EPS beats by $0.11, beats on revenue [5/6/2021 4:40 PM]	22.99	1.05 (4.79%)	22.01	0.07 (0.32%)	15.66 - 26.91	242,411	240,000	8,673
Collegium Pharmaceutical EPS beats by $0.11, beats on revenue [5/6/2021 4:40 PM] If You Had Bought Collegium Pharmaceutical (NASDAQ:COLL) Stock Five Years Ago, You Could Pocket A 47% Gain Today [May-06-21 03:22AM] Collegium Pharmaceutical, Inc. to Host Earnings Call [May-06-21 02:45PM] Collegium Reports Record Quarterly Revenue of $87.7 Million [May-06-21 04:01PM] Collegium Pharmaceutical (COLL) Beats Q1 Earnings and Revenue Estimates [May-06-21 06:20PM] Collegium Pharmaceutical Inc (COLL) Q1 2021 Earnings Call Transcript [May-06-21 08:31PM]
25-02-2021	AH	4:00 PM ET (Feb 25)	COLL	Collegium Pharmaceutical, Inc.	847.96	0.20	0.29	-0.07	Collegium Pharmaceutical EPS misses by $0.11, misses on revenue [2/25/2021 4:36 PM]	23.59	-2.44 (-9.37%)	26.75	0.72 (2.77%)	13.00 - 26.91	761,769	1,337,055	6,926
Collegium Pharmaceutical EPS misses by $0.11, misses on revenue [2/25/2021 4:36 PM] Collegium Reports Record Full-Year 2020 Revenue of $310.0 Million [Feb-25-21 04:01PM] Collegium Pharmaceutical, Inc. to Host Earnings Call [Feb-25-21 02:30PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	COLL	Collegium Pharmaceutical, Inc.	643.90	0.32	0.23	-0.18	Collegium Pharmaceutical EPS beats by $0.13, beats on revenue [11/5/2020 4:28 PM]	19.67	-0.36 (-1.80%)	21.00	0.97 (4.84%)	13.00 - 25.59	688,251	265,634	1,900

05-08-2020	AH	4:00 PM ET (Aug 5)	COLL	Collegium Pharmaceutical, Inc.	541.82	0.23	0.24	-0.14	Collegium Pharmaceutical EPS beats by $0.03, beats on revenue [8/5/2020 4:42 PM]	18.49	1.18 (6.82%)	18.90	1.59 (9.19%)	10.12 - 25.59	621,012	363,762	1,691